FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

122 hedge funds and large institutions have $762M invested in Fate Therapeutics in 2018 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 52 increasing their positions, 33 reducing their positions, and 19 closing their positions.

Holders
122
Holders Change
+6
Holders Change %
+5.17%
% of All Funds
2.72%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
25
Increased
52
Reduced
33
Closed
19
Calls
$2.57M
Puts
$2.43M
Net Calls
+$142K
Net Calls Change
-$193K

Top Buyers

1
AVM
1
Arch Venture Management
Illinois
$26.6M
2
FCM
2
Farallon Capital Management
California
$28.2M
3
BlackRock
3
BlackRock
New York
$64.6M
4
Victory Capital Management
4
Victory Capital Management
Texas
$16.9M
5
DM
5
Deerfield Management
New York
$21.2M

Top Sellers

1
Franklin Resources
1
Franklin Resources
California
$41.6M
2
PVMCV
2
Polaris Venture Management Co V
Massachusetts
$23.4M
3
Invesco
3
Invesco
Georgia
$909K
4
ACM
4
Aquilo Capital Management
California
$8.94M
5
ECM
5
Endurant Capital Management
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
RG
1
Redmile Group
California
$133M 10,359,666 – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$94.7M 7,380,302 -257,100 -3%
BlackRock
3
BlackRock
New York
$64.6M 5,031,783 +1,562,252 +45%
Franklin Resources
4
Franklin Resources
California
$41.6M 3,244,706 -2,113,559 -39%
CC
5
Casdin Capital
New York
$32.7M 2,550,000 – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$32.6M 2,541,990 +93,711 +4%
FCM
7
Farallon Capital Management
California
$28.2M 2,200,000 +1,670,000 +315%
AG
8
Artal Group
Luxembourg
$27.6M 2,150,000 -40,000 -2%
AVM
9
Arch Venture Management
Illinois
$26.6M 2,073,190 +2,073,190 New
State Street
10
State Street
Massachusetts
$26.1M 2,033,588 +78,748 +4%
PVMCV
11
Polaris Venture Management Co V
Massachusetts
$23.4M 1,823,186 -650,000 -26%
DM
12
Deerfield Management
New York
$21.2M 1,654,865 +481,248 +41%
PHS
13
PFM Health Sciences
California
$18.9M 1,471,000 -30,258 -2%
Victory Capital Management
14
Victory Capital Management
Texas
$16.9M 1,318,860 +791,540 +150%
Citadel Advisors
15
Citadel Advisors
Florida
$15.9M 1,238,442 +453,196 +58%
Westfield Capital Management
16
Westfield Capital Management
Massachusetts
$14.2M 1,104,305 +272,235 +33%
T. Rowe Price Associates
17
T. Rowe Price Associates
Maryland
$11.8M 916,624 +103,429 +13%
Northern Trust
18
Northern Trust
Illinois
$9.44M 735,512 +110,936 +18%
Geode Capital Management
19
Geode Capital Management
Massachusetts
$9.01M 702,179 +186,927 +36%
ACM
20
Aquilo Capital Management
California
$8.94M 697,096 -287,500 -29%
Millennium Management
21
Millennium Management
New York
$7.54M 587,640 +428,399 +269%
UBS AM
22
UBS AM
Illinois
$6.59M 513,504 +447,726 +681%
JPMorgan Chase & Co
23
JPMorgan Chase & Co
New York
$5.9M 459,893 +17,511 +4%
6CM
24
683 Capital Management
New York
$5.2M 405,000 -244,800 -38%
Morgan Stanley
25
Morgan Stanley
New York
$4.73M 368,466 +157,543 +75%
1
2 3 4 5